The Federal Circuit limits the reach of the on sale bar and provides guidance to pharmaceutical companies that rely on the use of contract manufacturers. Bruce Haas and Lauren Zuffante discuss.
Related Services
Related Insights
Identical Marks, Identical Types of Products: Not Enough to Presume Confusion
Identical Marks, Identical Types of Products: Not Enough to Presume Confusion
October 15, 2020
1min
Adapting to a ‘Normal’ Hybrid Trial During the Pandemic
Adapting to a ‘Normal’ Hybrid Trial During the Pandemic
October 12, 2020
1min
Fighting Counterfeits at the U.S. Border: The Counterfeit Goods Seizure Act of 2019 Would Expand Customs and Border Patrol Enforcement to Design Patents
Fighting Counterfeits at the U.S. Border: The Counterfeit Goods Seizure Act of 2019 Would Expand Customs and Border Patrol Enforcement to Design Patents
August 13, 2020
6min
Events
Virtual Post-Election Series
Virtual Post-Election Series
November 4-6, 2020 Venable LLP
ANA/BAA Marketing Law Conference 2020
ANA/BAA Marketing Law Conference 2020
November 10 - 12, 2020 ANA/BAA Marketing Law Conference
Recent News
Politico Pro Quotes Jim Burnley on the Potential Impact of Oregon Congressional Race on Infrastructure
Politico Pro Quotes Jim Burnley on the Potential Impact of Oregon Congressional Race on Infrastructure
October 23, 2020
1min
The Network Journal Recognizes JaMar Mancano Among Its 2019 40 Under Forty
The Network Journal Recognizes JaMar Mancano Among Its 2019 40 Under Forty
October 22, 2020
1min
Baltimore Business Journal Features Venable’s Diversity and Inclusion Initiatives
Baltimore Business Journal Features Venable’s Diversity and Inclusion Initiatives
October 20, 2020
1min